ClinicalTrials.gov
public full text
Public Domain
A Study to Measure Mirikizumab Levels in Breast Milk of Lactating Participants Receiving Mirikizumab Therapeutically for an Approved Indication
The main purpose of this study is to assess the amount of mirikizumab in breast milk in women who are breastfeeding who are receiving stable maintenance doses of mirikizumab for an approved indication. Participation in this study could last up to 94 days, including screening and follow-up period.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Human Milk Fortifier and Cytokine Profile#1072910
- Hubungan Pengetahuan Manajemen Laktasi dengan Pemberian ASI Eksklusif pada Ibu Menyusui: Relationship in Lactation Management with Exclusive Breastfeeding on Nursing Mothers#1003990
- Postmarketing Vedolizumab Milk-Only Lactation Study in Lactating Women With Active Ulcerative Colitis or Crohn's Disease#1281518
- Elucidation of Breast Milk Composition and Structure Over the First Year of Lactation: UC Davis Lactation Study#1115171
- Infant Immunity Comparison of Breastfed and Bottlefed Infants#1111710
Record · ID 1243986
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive